Healthcare provider profile · identity verified

Elizabeth Davies, MD

Family Practice · WAUKESHA, WI · NPI 1164594016

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	323	120
Levothyroxine Sodium	Levothyroxine Sodium	312	110
Atorvastatin Calcium	Atorvastatin Calcium	211	77
Amlodipine Besylate	Amlodipine Besylate	192	67
Metoprolol Succinate	Metoprolol Succinate	184	62
Losartan Potassium	Losartan Potassium	162	55
Lisinopril	Lisinopril	156	54
Pantoprazole Sodium	Pantoprazole Sodium	150	55
Simvastatin	Simvastatin	125	46
Omeprazole	Omeprazole	106	44
Eliquis	Apixaban	96	16
Metformin Hcl Er	Metformin Hcl	95	41
Escitalopram Oxalate	Escitalopram Oxalate	92	37
Gabapentin	Gabapentin	83	40
Potassium Chloride	Potassium Chloride	81	29
Pravastatin Sodium	Pravastatin Sodium	81	31
Metformin Hcl	Metformin Hcl	79	20
Furosemide	Furosemide	75	36
Warfarin Sodium	Warfarin Sodium	73	14
Trazodone Hcl	Trazodone Hcl	71	32
Sertraline Hcl	Sertraline Hcl	69	19
Valsartan	Valsartan	69	27
Duloxetine Hcl	Duloxetine Hcl	60	20
Bupropion Xl	Bupropion Hcl	57	20
Tramadol Hcl	Tramadol Hcl	54	16
Famotidine	Famotidine	53	12
Hydrochlorothiazide	Hydrochlorothiazide	53	23
Atenolol	Atenolol	48	21
Montelukast Sodium	Montelukast Sodium	46	18
Clopidogrel	Clopidogrel Bisulfate	38	14
Januvia	Sitagliptin Phosphate	37	13
Glimepiride	Glimepiride	35	suppressed
Mirtazapine	Mirtazapine	35	14
Tamsulosin Hcl	Tamsulosin Hcl	34	17
Irbesartan	Irbesartan	33	15
Metoprolol Tartrate	Metoprolol Tartrate	33	13
Spironolactone	Spironolactone	32	12
Jardiance	Empagliflozin	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Clonazepam	Clonazepam	28	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Ozempic	Semaglutide	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	13
Bumetanide	Bumetanide	26	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	13
Allopurinol	Allopurinol	25	14
Fluoxetine Hcl	Fluoxetine Hcl	25	11
Lorazepam	Lorazepam	25	15
Carvedilol	Carvedilol	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	11
Fluconazole	Fluconazole	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	17
Mounjaro	Tirzepatide	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	19	16
Celecoxib	Celecoxib	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	14
Alprazolam	Alprazolam	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	16
Mesalamine Dr	Mesalamine	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Ondansetron Odt	Ondansetron	16	12
Xarelto	Rivaroxaban	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Cephalexin	Cephalexin	14	12
Donepezil Hcl	Donepezil Hcl	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Estradiol	Estradiol	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error